Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06699420 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Qishenyiqi Dripping Pill for Coronary Microvascular Disease

Study acronym: CMVD
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 21, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Trial Details
NCT Number NCT06699420
Lead Sponsor Qilu Hospital of Shandong University
Conditions
(from sponsor)		 Coronary Microvascular Disease
Related terms Microvascular Angina
Enrollment 162 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov